Although prostatic cancer cells are generally recognized as androgen dependent, recent compelling evidence suggests that other steroids, such as 25-dihydroxyvitamin D3 [1 alpha, 25(OH)2D3], are involved in the growth modulation and differentiation of such cells, mediated by their respective receptors. The androgen-receptor gene, located on chromosome X1, carried a highly polymorphic microsatellite on exon 1, a trinucleotide (CAG) repeat sequence. The size of this repeat normally varies from 9 to 31 repeats.
There is a racial difference in the CAG repeat polymorphism: the entire allele frequency pro®le is shifted toward shorter alleles in African-Americans and longer alleles in Asian-Americans when compared with White Americans. The size of this repeat sequence is inversely associated with the intensity of transactivation of androgen-responsive genes and with the reported incidence of prostate cancer in these populations.
Prostate cancer susceptibility may also depend on genetic polymorphism of a poly-A microsatellite in the 3 0 -untranslated region (3 0 UTR) of the vitamin D receptor. There is a signi®cant variation of incidence and mortality across countries and ethnic groups. African-Americans have, by far, the highest reported prostate cancer incidence and mortality rates. Despite the different origins of African descendants between North America and Brazil, the incidence of prostate cancer detection in AfricanBrazilians was consistently higher than in other ethnic groups screened with prostate-speci®c antigen (PSA) and DRE in our population: the relative risk of cancer detection was 2.7 times higher in the former group, as reported in the ®rst Innovators Meeting held in London in 1998. In 1701±1843, approximately 2.4 million Africans were brought to Brazil, mostly from African ports of Portuguese in¯uence in regions inhabited by Bantu populations, such as Angola, Congo and Mozambique. Africans transported to the USA and Jamaica had a different origin (Benin ethnic group), coming mainly from Central±West African ports.
We are prospectively collecting snap-frozen specimens from tumour and normal tissue from patients of different races treated in our institution. Controls will be represented by age-matched healthy patients for each race, as well as by age-matched patients undergoing transurethral resection of the prostate (TURP) for benign disease. For these analyses, DNA extraction and polymerase chain reaction (PCR) techniques will be performed with speci®c primers for ampli®cation of these polymorphic regions in both androgen-receptor genes and vitamin D receptors in separate reactions, and studied by an automated sequencer. We aim to evaluate 100 prostate cancer cases, 100 benign prostatic hyperplasia cases and 300 age-matched healthy controls, equally distributed between ethnic groups. Preliminary results of this work in-progress will be presented at the meeting.
